Zhen Li
CIK 1729510 · Snr. VP, Chem and Non-Clin Dev · last filed 2019-01-16
Zhen Li is a Snr. VP, Chem and Non-Clin Dev who has filed 2 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing shows the insider sold $580.8K of ARWR on Jan 16, 2019. Across all open-market trades the lifetime net is −$580.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $16.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$16.56M
1
2
-$580.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARWR | Snr. VP, Chem and Non-Clin Dev | 201,700 | $82.09 | $16.56M | -$580.8K | 2 | 2019-01-16 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-16 | ARWR | Sell (S) | −40,500 | -$580.8K | EDGAR |
| 2019-01-03 | ARWR | Grant (A) | +75,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.